04/07/2024
11:15 PM | Aura Biosciences (Filer)
| Form EFFECT | |
04/04/2024
3:10 PM | Aura Biosciences (Issuer)
Kilroy Conor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
6:59 AM | Aura Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2024
7:12 AM | Aura Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/27/2024
6:11 AM | Aura Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
6:05 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
3:22 PM | Aura Biosciences (Subject)
Rich Cadmus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/14/2024
3:57 PM | Aura Biosciences (Subject)
CITADEL ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/07/2024
6:54 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Aura Biosciences (Subject)
| Form SC 13G/A | |
01/24/2024
3:20 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:31 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
3:29 PM | Aura Biosciences (Subject)
Rich Cadmus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023
3:30 PM | Aura Biosciences (Subject)
Rich Cadmus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023
3:20 PM | Aura Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
5:09 PM | Aura Biosciences (Issuer)
Feder Julie B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
5:19 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
3:55 PM | Aura Biosciences (Filer)
| Form 424B5 | |
11/06/2023
3:17 PM | Aura Biosciences (Filer)
| Form 424B5 | |
11/06/2023
3:20 PM | Aura Biosciences (Subject)
Feder Julie B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023
3:22 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023
5:21 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
5:24 PM | Aura Biosciences (Issuer)
Feder Julie B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:51 PM | Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/05/2023
6:56 PM | Aura Biosciences (Issuer)
Johnson David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
3:11 PM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2023
6:05 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2023
6:10 AM | Aura Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/07/2023
4:46 PM | Aura Biosciences (Subject)
De Rosch Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
3:52 PM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
6:11 PM | Aura Biosciences (Subject)
De Rosch Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
